Rockwell Medical
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 237
- Market Cap
- $95.2M
- Website
- http://www.rockwellmed.com
- Introduction
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Clinical Trials
21
Trial Phases
4 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05110768
Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04689932
- Locations
- 🇺🇸
Luxury Dialysis, Webster, Texas, United States
Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT04409132
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT04239391
- Locations
- 🇺🇸
Loma Linda University Hospital, Loma Linda, California, United States
🇺🇸Childrens Hospital National Medical Center, Washington, District of Columbia, United States
🇺🇸Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States
A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04042324
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- Next